Artesunate inhibited human tongue squamous cell carcinoma CAL27 cells in vitro via STAT3 signaling pathway

doi:10.19439/j.sjos.2022.01.007

Abstract

Abstract: PURPOSE: To investigate the anticancer effect of artesunate(ART) on human tongue squamous cell carcinoma (CAL27) cells and its possible mechanism. METHODS: CAL27 cells was pretreated with different doses of ART. Then, CCK-8 and colony forming methods were used for cell viability analysis, cell apoptosis was detected by flow cytometry, and cell migration and invasion capacity were determined by scratch test and Transwell chamber method. In addition, the expression of matrix metalloproteinase-9 (MMP-9) and vascular endothelial growth factor (VEGF) mRNA was measured by qPCR, and Western blot was used to detect the expression of MMP-9 and VEGF and activation of STAT3 signal in CAL27 cells treated with ART at various concentrations. SPSS 19.0 software package was used for statistical analysis of the data. RESULTS: Artesunate significantly inhibited proliferation(P<0.01), invasion(P<0.01)and migration(P<0.01) of CAL27 cells,and induced apoptosis of CAL27 cells (P<0.01) in a dose-dependent manner. ART not only significantly reduced the expression of MMP-9 and VEGF mRNA in CAL27 cells in a dose-dependent manner(P<0.05), but also inhibited the protein expression of p-STAT3, MMP-9 and VEGF. CONCLUSIONS: Artesunate can inhibit the proliferation, migration and invasion of CAL27 cells, which may exert antitumor effects by inhibiting the STAT3 signaling pathway.

Key words: Tongue squamous cell carcinoma, CAL27, Artesunate, STAT3

CLC Number:

R739.8

LI Meng, SUN Jin-hu, MENG Jian. Artesunate inhibited human tongue squamous cell carcinoma CAL27 cells in vitro via STAT3 signaling pathway[J]. Shanghai Journal of Stomatology, 2022, 31(1): 32-37.

References

[1] Bray F, Ferlay J, Soerjomataram I, et al.Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68(6): 394-424.
[2] Rosebush MS, Rao SK, Samant S, et al.Oral cancer: enduring characteristics and emerging trends[J]. J Mich Dent Assoc, 2011, 91(2): 24-29.
[3] Xie N, Wang C, Liu X, et al.Tumor budding correlates with occult cervical lymph node metastasis and poor prognosis in clinical early-stage tongue squamous cell carcinoma[J]. J Oral Pathol Med, 2015, 44(4): 266-272.
[4] Zhang YY, Wang DC, Su JZ, et al.Clinicopathological characteristics and outcomes of squamous cell carcinoma of the tongue in different age groups[J]. Head Neck, 2017, 39(11): 2276-2282.
[5] No authors listed. Chemical studies on qinghaosu (artemisinine) China cooperative research group on qinghaosu and its derivatives as antimalarials[J]. J Tradit Chin Med, 1982, 2(1): 3-8.
[6] 胡莲洁, 姜涛, 王甫珏, 等.青蒿琥酯联合硼替佐米对急性髓系白血病细胞体外凋亡、自噬的影响及其作用机制[J].中华血液学杂志, 2019, 40(3): 204-208.
[7] Jing W, Dong H, Min M, et al.Dependence of artesunate on long noncoding RNA-RP11 to inhibit epithelial-mesenchymal transition of hepatocellular carcinoma[J]. J Cell Biochem, 2019, 120(4): 6026-6034.
[8] König M, von Hagens C, Hoth S, et al. Investigation of ototoxicity of artesunate as add-on therapy in patients with metastatic or locally advanced breast cancer: new audiological results from a prospective, open, uncontrolled, monocentric phase I study[J]. Cancer Chemother Pharmacol, 2016, 77(2): 413-427.
[9] Xiao Q, Yang L, Hu H, et al.Artesunate targets oral tongue squamous cell carcinoma via mitochondrial dysfunction-dependent oxidative damage and Akt/AMPK/mTOR inhibition[J]. J Bioenerg Biomembr, 2020, 52(2):113-121.
[10] Li Q, Ni W, Deng Z, et al.Targeting nasopharyngeal carcinoma by artesunate through inhibiting Akt/mTOR and inducing oxidative stress[J]. Fundam Clin Pharmacol, 2017, 31(3): 301-310.
[11] Yang Y, Wu N, Wu Y, et al.Artesunate induces mitochondria-mediated apoptosis of human retinoblastoma cells by upregulating Kruppel-like factor 6[J]. Cell Death Dis, 2019, 10(11): 862-862.
[12] 李亚光, 蔡捷, 唐东平, 等. 青蒿琥酯联合阿霉素对人舌鳞癌Tca8113细胞抑制作用的实验研究[J].世界中西医结合杂志, 2010, 5(9):752-754.
[13] Shi R, Cui H, Bi Y, et al.Artesunate altered cellular mechanical properties leading to deregulation of cell proliferation and migration in esophageal squamous cell carcinoma[J]. Oncol Lett, 2015, 9(5): 2249-2255.
[14] Wang N, Chen H, Teng Y, et al.Artesunate inhibits proliferation and invasion of mouse hemangioendothelioma cells in vitro and of tumor growth in vivo[J]. Oncol Lett, 2017, 14(5): 6170-6176.
[15] Verma S, Das P, Kumar VL.Chemoprevention by artesunate in a preclinical model of colorectal cancer involves down regulation of β-catenin, suppression of angiogenesis, cellular proliferation and induction of apoptosis[J]. Chem Biol Interact, 2017, 278: 84-91.
[16] Xu XD, Shen HB, Zhu L, et al.Anti-RhoC siRNAs inhibit the proliferation and invasiveness of breast cancer cells via modulating the KAI1, MMP9, and CXCR4 expression[J]. Onco Targets Ther, 2017, 10:1827-1834.
[17] Bhattacharya R, Fan F, Wang R, et al.Intracrine VEGF signalling mediates colorectal cancer cell migration and invasion[J]. Br J Cancer, 2017, 117(6): 848-855.
[18] Ilamathi M, Prabu PC, Ayyappa KA, et al.Artesunate obliterates experimental hepatocellular carcinoma in rats through suppression of IL-6-JAK-STAT signaling[J]. Biomed Pharmacother, 2016, 82: 72-79.
[19] Yeh JE, Frank DA.STAT3-interacting proteins as modulators of transcription factor function: implications to targeted cancer therapy[J]. Chem Med Chem, 2016, 11(8):795-801.
[20] Aryappalli P, Shabbiri K, Masad RJ, et al.Inhibition of tyrosine-phosphorylated STAT3 in Human breast and lung cancer cells by manuka honey is mediated by selective antagonism of the IL-6 receptor[J]. Int J Mol Sci, 2019, 20(18): 4340.
[21] Ilamathi M, Santhosh S, Sivaramakrishnan V.Artesunate as an anti-cancer agent targets Stat-3 and favorably suppresses hepatocellular carcinoma[J]. Curr Top Med Chem, 2016, 16(22):2453-2463.
[22] Tan M, Rong Y, Su Q, et al.Artesunate induces apoptosis via inhibition of STAT3 in THP-1 cells[J]. Leuk Res, 2017, 62:98-103.